Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03448718
Title Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Matthew Galsky
Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST